About: Cardiac tamponade in COVID‐19 patients: Management and outcomes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cardiac tamponade in COVID‐19 patients: Management and outcomes Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Cardiac tamponade in COVID‐19 patients: Management and outcomes
Creator	Abrol, Sunil Beevash, \| Brathwaite, Collin Hakmi, Hazim Md, Ray Sohail, \|
Source	Medline; PMC
abstract	IMPORTANCE: Cardiac tamponade requiring emergent intervention is a possible complication of coronavirus disease 2019 (COVID‐19) infection. Favorable clinical outcomes are possible if timely management and drainage are performed unless ventricular failure develops. OBSERVATION: Cardiac tamponade in COVID‐19, based on the limited reported cases, seems to be more common among middle‐aged men with observed complications in black and ethnic minorities. Prognosis is worse amongst patients with concomitant ventricular failure. DESIGN AND METHODS: This is a case series of three COVID‐19 patients complicated by cardiac tamponade, requiring surgical intervention at a single institution in New York. INTERVENTION: Pericardial window, Pericardiocentesis. OUTCOME: One patient had recurrence of cardiac tamponade with hemorrhagic component but fully recovered and was discharged home. Two patients developed cardiac tamponade with concomitant biventricular failure, resulting in death. CONCLUSION AND RELEVANCE: Cardiac tamponade with possible concomitant biventricular failure can develop in COVID‐19 patients; incidence seems to be highest at the point of marked inflammatory response. Concomitant ventricular failure seems to be a predictor of poor prognosis.
has issue date	2020-08-13(xsd:dateTime)
bibo:doi	10.1111/jocs.14925
bibo:pmid	32790006
has license	no-cc
sha1sum (hex)	7e61adbb0f0f8bd4fc44236d004772f7a398d683
schema:url	https://doi.org/10.1111/jocs.14925
resource representing a document's title	Cardiac tamponade in COVID‐19 patients: Management and outcomes
has PubMed Central identifier	PMC7436377
has PubMed identifier	32790006
schema:publication	J Card Surg
resource representing a document's body	covid:7e61adbb0f0f8bd4fc44236d004772f7a398d683#body_text
is schema:about of	named entity 'complication' named entity 'broad spectrum' named entity '11 March 2020' named entity 'anticoagulation' named entity 'cardiovascular' named entity 'emergent' named entity 'coronavirus disease 2019' named entity 'COVID-19' named entity 'COVID-19' named entity 'COVID-19' named entity 'prophylactic' named entity 'inflammatory process' named entity 'cardiovascular' named entity 'COVID' named entity 'COVID-19' named entity 'physiology' named entity 'decompensation' named entity 'infection' named entity 'acute respiratory distress syndrome' named entity 'cardiac tamponade' named entity 'hypercoagulability' named entity 'anti-inflammatory medications' named entity 'World Health Organization' named entity 'anticoagulation' named entity 'pericardial effusion' named entity 'COVID' named entity 'physiology' named entity 'pericardial fluid' named entity 'myocarditis' named entity 'obstructive shock' named entity 'acute kidney injury' named entity 'surgical intervention' named entity 'congestive heart failure' named entity 'percutaneous' named entity 'cardiac tamponade' named entity 'cytology' named entity 'pericardial effusion' named entity 'cardiac tamponade' named entity 'coronavirus disease 2019' named entity 'COVID-19.' named entity 'inflammatory markers' named entity 'pericardial' named entity 'therapeutic dose' named entity 'anticoagulation' named entity 'Arrhythmias' named entity 'cardiac tamponade' named entity 'elective surgeries' named entity 'pericardial fluid' named entity 'secondary infection' named entity 'treatment of patients' named entity 'Pericardiocentesis' named entity 'immunosuppressive' named entity 'Cardiac tamponade' named entity 'NYU Langone Health' named entity 'ventricular failure' named entity 'NYU Winthrop Hospital' named entity '1-8' named entity 'infection' covid:arg/7e61adbb0f0f8bd4fc44236d004772f7a398d683 named entity 'clinical outcomes' named entity 'infection' named entity 'Cardiac tamponade' named entity 'coronavirus disease 2019' named entity 'drainage' named entity 'management' named entity 'performed' named entity 'COVID-19' named entity 'ventricular' named entity 'timely' named entity 'NYU Winthrop Hospital' named entity 'Station' named entity 'Correspondence' named entity 'NYU Langone Health' named entity 'Plaza'
is wasQuotedFrom of	covid:arg/7e61adbb0f0f8bd4fc44236d004772f7a398d683/0
is part of of	Cardiac tamponade in COVID‐19 patients: Management and outcomes

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software